Disease activity courses in a regional cohort of Crohn's disease patients.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Scandinavian Journal of Gastroenterology

• Publication date

  1995-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/00365529509096316PMID 7481535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.

  1993cited by this paper
• Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

  1993cited by this paper
• Intestinal cancer risk and mortality in patients with Crohn's disease.

  1993cited by this paper
• Perceived discrimination in education and employment by people with Crohn's disease: a case control study of educational achievement and employment.

  1992cited by this paper
• Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease

  1992cited by this paper
• Results of surgical treatment of patients with Crohn's disease.

  1992cited by this paper
• Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group.

  1992cited by this paper
• Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence.

  1992cited by this paper
• Predictability of the postoperative course of Crohn's disease.

  1990cited by this paper
• A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

  1989cited by this paper
• Life prospects and quality of life in patients with Crohn's disease.

  1987cited by this paper
• Alimentary tract andpancreas Prognosis inCrohn's disease -based onresults froma regional patient group fromthecounty ofCopenhagen

  1985cited by this paper
• European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.

  1984cited by this paper
• European cooperative Crohn's disease study (ECCDS) : Results of drug treatment

  1984cited by this paper
• Risk factors for postoperative recurrence of Crohn's disease.

  1983cited by this paper
• Clinical features and natural history of Crohn's disease.

  1979cited by this paper
• National Cooperative Crohn's Disease Study: results of drug treatment.

  1979cited by this paper
• The social toll of Crohn's disease.

  1978cited by this paper
• Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease.

  1976cited by this paper
• Non-Parametric Statistics for the Behavioral Sciences.

  1957cited by this paper

• ACG Clinical Guideline: Management of Crohn's Disease in Adults

  2025cites this paper
• Global, Regional, and National Burdens of Inflammatory Bowel Disease in Women of Reproductive Age (15–49 Years) from 1992 to 2021

  2025cites this paper
• Practices and perceptions of 5-aminosalicylic acid use in Crohn’s disease: a nationwide survey of physicians in Korea by KASID Guidelines Taskforce Team

  2025cites this paper
• Editorial: Endoscopic Activity is an Essential Tool for Patients' Management, Even in Mild Crohn's Disease

  2025cites this paper
• Role of Endoscopic Ultrasound in the Diagnosis and Management of Complications of Inflammatory Bowel Disease.

  2024cites this paper
• Primary surgery versus pharmacotherapy for newly diagnosed ileocecal Crohn’s disease: a hospital-based cohort study

  2024cites this paper
• Lemann Index for assessing bowel damage in Crohn's disease: a real world study.

  2024cites this paper
• Infliximab for maintenance of medically-induced remission in Crohn's disease.

  2024cites this paper
• The Natural History of Crohn's Disease Leading to Intestinal Failure: A Longitudinal Cohort Study from 1973 to 2018.

  2024cites this paper
• Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-Based Cohort Study 1997-2020.

  2024cites this paper
• Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline

  2024cites this paper
• Disease Activity Patterns of Paediatric Inflammatory Bowel Disease - A Danish Nationwide Cohort Study (1996-2018).

  2023cites this paper
• Related Factors for Unfavorable Disease Course in Patients with Crohn’s Disease: An Observational Retrospective Study

  2023cites this paper
• Mild Crohn’s Disease: Definition and Management

  2023cites this paper
• Infliximab for medical induction of remission in Crohn's disease

  2023cites this paper
• Expert opinions on informational and supportive needs and sources of obtaining information in patients with inflammatory bowel disease: a Delphi consensus study

  2023cites this paper
• Incorporation of Plant-Based Diet Surpasses Current Standards in Therapeutic Outcomes in Inflammatory Bowel Disease

  2023influential citation
• Long‐term disease course, cost and prognosis of inflammatory bowel disease: epidemiological studies of a European and a Danish inception cohort

  2023influential citation
• Monitoring of patients with active inflammatory bowel disease

  2023cites this paper
• Therapeutic advancement in inflammatory bowel disease by incorporating plant-based diet

  2023cites this paper
• Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004

  2022cites this paper
• Relapse-Free Course in Nearly Half of Crohn's Disease Patients With Infliximab and Plant-Based Diet as First-Line Therapy: A Single-Group Trial.

  2022cites this paper
• A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease

  2022cites this paper
• Imaging Evaluation of Inflammatory Bowel Disease Complications.

  2022cites this paper
• Disease Activity Patterns of Inflammatory Bowel Disease - A Danish Nationwide Cohort Study 1995-2018.

  2022cites this paper
• The clinical course of Crohn’s disease in a Danish population‐based inception cohort with more than 50 years of follow‐up, 1962‐2017

  2021cites this paper
• Transmural Response and Transmural Healing Defined by Intestinal Ultrasound - New Potential Therapeutic Targets?

  2021cites this paper
• Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study

  2021cites this paper
• Association between vedolizumab and postoperative complications in IBD: a systematic review and meta-analysis

  2021cites this paper
• Utility of FDG PET/CT in assessing bowel inflammation.

  2021cites this paper
• Relevance of monitoring transmural disease activity in patients with Crohn’s disease: current status and future perspectives

  2021cites this paper
• Physical activity and quality of life of patients with inflammatory bowel disease

  2021cites this paper
• Epidemiology and Risk Factors for Hospitalization in Patients with Ulcerative Colitis and Crohn’s Disease

  2021cites this paper
• Prognostic tools for identification of high risk in people with Crohn's disease: systematic review and cost-effectiveness study.

  2021cites this paper
• Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors

  2021cites this paper
• Crohn's Disease

  2020cites this paper
• Treatment Algorithms for Crohn’s Disease

  2020cites this paper
• Epidemiologie der chronisch-entzündlichen Darmerkrankungen

  2020cites this paper
• The Role of Inflammation in Crohn's Disease Recurrence after Surgical Treatment

  2020cites this paper
• Normalization of Fecal Calprotectin Within 12 Months of Diagnosis is Associated with Reduced Risk of Disease Progression in Patients with Crohn's Disease.

  2020cites this paper
• Prevention and Treatment of Stricturing Crohn’s Disease – Perspectives and Challenges

  2020cites this paper
• Examining Risk Factors of Health-Related Quality of Life Impairments Among Adolescents with Inflammatory Bowel Disease

  2020cites this paper
• Clinical Features of Intra-Abdominal Abscess and Intestinal Free-Wall Perforation in Korean Patients with Crohn’s Disease: Results from the CONNECT Study

  2020cites this paper
• Early Indolent Course of Crohn's Disease in Newly Diagnosed Patients is Not Rare and Possibly Predictable.

  2020cites this paper
• Prototype single-balloon enteroscopy with passive bending and high force transmission improves depth of insertion in the small intestine

  2020cites this paper
• Stem Cell Therapy for Perianal Crohn’s Disease

  2020cites this paper
• Fibrostenotic strictures in Crohn’s disease

  2020cites this paper
• Long term remission after ileorectal anastomosis in Crohn's colitis.

  2020cites this paper
• The use of 5-aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow-up – an Epi-IBD study

  2020cites this paper
• Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn’s disease in clinical remission

  2020cites this paper
• Dietary Patterns Associated to Clinical Aspects in Crohn’s Disease Patients

  2020cites this paper
• Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow Up in a Danish Population-Based Inception Cohort.

  2019cites this paper
• Precision Medicine in Inflammatory Bowel Disease

  2019cites this paper
• Low-dose biologics to treat inflammatory bowel disease. Ready for prime time?

  2019cites this paper
• Gammadelta T cells as a predictor of surgical relapse of Crohn's disease.

  2019cites this paper
• Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome—directions for future research

  2019cites this paper
• Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn’s Disease: Single-Center Series

  2019cites this paper
• Penetrating Crohn Disease Is Not Associated With a Higher Risk of Recurrence After Surgery: A Prospective Nationwide Cohort Conducted by the Getaid Chirurgie Group.

  2019cites this paper
• Benefit–Risk Assessment of Vedolizumab in the Treatment of Crohn’s Disease and Ulcerative Colitis

  2019cites this paper
• Risk of impaired nutritional status and flare occurrence in IBD outpatients.

  2019cites this paper
• Pharmacoeconomical Impacts of Crohn’s Disease

  2019cites this paper
• A product review of vedolizumab in inflammatory bowel disease

  2019cites this paper
• Prognosticating the Course of Inflammatory Bowel Disease.

  2019cites this paper
• The PROMise of remote monitoring to improve quality of care for inflammatory bowel disease

  2019cites this paper
• Determinants of Hospital Costs of Inflammatory Bowel Disease

  2019cites this paper
• Pharmacodynamic monitoring of biological therapies in chronic inflammatory diseases.

  2019cites this paper
• EVALUATING LOCATION OF BIOPSY PROCUREMENT IN ACTIVE CROHN'S DISEASE

  2019influential citation
• Infliximab Dependency in a National Cohort of Children with Crohn’s Disease

  2018cites this paper
• Ustekinumab for Treating Moderately to Severely Active Crohn’s Disease after Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

  2018cites this paper
• Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn’s Disease

  2018cites this paper
• Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease.

  2018cites this paper
• Postoperative outcomes in vedolizumab‐treated Crohn's disease patients undergoing major abdominal operations

  2018cites this paper
• Efficacy of Endoscopic Balloon Dilation for Small Bowel Strictures in Patients With Crohn’s Disease: A Nationwide, Multi-centre, Open-label, Prospective Cohort Study

  2018cites this paper
• Chapter 1 Inflammatory Bowel Disease : Epidemiology

  2018cites this paper
• Stem Cell Therapy for Perianal Crohn's Disease.

  2018cites this paper
• Segmental Resection versus Total Proctocolectomy for Crohn's Colitis: What is the Best Operation in the Setting of Medically Refractory Disease or Dysplasia?

  2018cites this paper
• Investigating the natural history, serologic and genetic associations with disease outcomes, disability and cost of care in inflammatory bowel disease

  2018cites this paper
• Direct health‐care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis

  2018cites this paper
• Epidemiology and Natural History of Fibrostenosing Inflammatory Bowel Disease

  2018cites this paper
• Magnetic Resonance Imaging of a population-based Cohort of Patients with Long-term Inflammatory Bowel disease. Primary sclerosing cholangitis, bowel damage and inflammation

  2018cites this paper
• Therapeutic preferences and outcomes in newly diagnosed patients with Crohn’s diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database

  2018cites this paper
• Stricturing Crohn’s Disease: Strictureplasty

  2018cites this paper
• Risk factors for diagnostic delay in Crohn's disease and their impact on long‐term complications: how do they differ in a tuberculosis endemic region?

  2018cites this paper
• Antitumor Necrosis Factor Agents in Crohn’s Disease

  2018cites this paper
• Clinical management of Anti‐TNF‐alpha‐induced psoriasis or psoriasiform lesions in inflammatory bowel disease patients: a systematic review

  2018cites this paper
• Epithelial down‐regulation of the miR‐200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition

  2018cites this paper
• Development of Clinical Prediction Models for Surgery and Complications in Crohn’s Disease

  2018cites this paper
• Differential Diagnosis of Inflammatory Bowel Disease: Endoscopic Findings and Diagnosis of Intestinal Behçet’s Disease and Simple Ulcer Syndrome

  2018cites this paper
• ACG Clinical Guideline: Management of Crohn’s Disease in Adults

  2018cites this paper
• Endoscopic Therapy of Intestinal Strictures: What Is State of the Art?

  2018cites this paper
• The Natural History of IBD: Lessons Learned

  2018cites this paper
• Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index.

  2017cites this paper
• Title : Direct Health Care Cost Utilization in Hong Kong Inflammatory Bowel Disease Patients in the Initial 2 Years Following Diagnosis Short running title : Cost utilization in Hong Kong IBD patients

  2017cites this paper
• A comprehensive review and update on Crohn's disease.

  2017cites this paper
• Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability.

  2017cites this paper
• Inflammatory Bowel Diseases: How to Identify High-Risk Patients

  2017cites this paper
• Current status of endoscopic balloon dilation for Crohn's disease

  2017cites this paper
• Induction with Infliximab and a Plant-Based Diet as First-Line (IPF) Therapy for Crohn Disease: A Single-Group Trial.

  2017cites this paper
• The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease

  2017cites this paper
• A rolling phenotype in Crohn's disease

  2017cites this paper